Diabetes mellitus and COVID-19: current state of knowledge
Introduction: Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate metabolism. Long-term high blood glucose levels can lead to a variety of serious complications and organ failure. Diabetic patients are particularly at risk of the severe course of COVID-1...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2022-08-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/39559 |
_version_ | 1828109789231579136 |
---|---|
author | Inga Wasilewska Jakub Rezmer Łukasz Świątek |
author_facet | Inga Wasilewska Jakub Rezmer Łukasz Świątek |
author_sort | Inga Wasilewska |
collection | DOAJ |
description |
Introduction:
Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate metabolism. Long-term high blood glucose levels can lead to a variety of serious complications and organ failure. Diabetic patients are particularly at risk of the severe course of COVID-19.
Objective:
The study aimed to investigate the relationship between diabetes and COVID-19. The literature available in the PubMed database was used to carry out a systematic review of the literature. The meta-analyzes from 2021 and 2022 were used for the analysis, with the inclusion of the phrases "DIABETES" and "COVID-19" in the title.
A brief description of the state of knowledge:
Diabetes does not increase the incidence of COVID-19, but the risk of severe disease is higher in patients with diabetes compared to the non-diabetic population. This is especially true of patients with uncontrolled glycaemia. SARS-CoV-2 disrupts the carbohydrate metabolism, can damage pancreatic beta cells and, in this mechanism, induce diabetes or cause the progression of pre-existing diabetes. There is an increased incidence of COVID-19 complications, including acute respiratory distress syndrome and death in patients with diabetes.
Conclusions:
Diabetic patients are at a higher risk of the severe course and rapid progression of COVID-19. Important in COVID-19 therapy is glycemic control and monitoring the percentage of glycosylated hemoglobin, CRP and D-dimers. The modification of the current treatment may be necessary. In patients who have undergone COVID-19, attention should be paid to the possibility of induction of diabetes or dysregulation of carbohydrate metabolism in patients suffering from diabetes previously.
|
first_indexed | 2024-04-11T11:09:46Z |
format | Article |
id | doaj.art-86b209d35cef42308fc35baf07b75e43 |
institution | Directory Open Access Journal |
issn | 2391-8306 |
language | English |
last_indexed | 2024-04-11T11:09:46Z |
publishDate | 2022-08-01 |
publisher | Kazimierz Wielki University |
record_format | Article |
series | Journal of Education, Health and Sport |
spelling | doaj.art-86b209d35cef42308fc35baf07b75e432022-12-22T04:27:57ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062022-08-0112810.12775/JEHS.2022.12.08.101Diabetes mellitus and COVID-19: current state of knowledgeInga Wasilewska0Jakub Rezmer1Łukasz Świątek2Uniwersytet Medyczny w LublinieUniwersytet Medyczny w LublinieUniwersytet Medyczny w Lublinie Introduction: Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate metabolism. Long-term high blood glucose levels can lead to a variety of serious complications and organ failure. Diabetic patients are particularly at risk of the severe course of COVID-19. Objective: The study aimed to investigate the relationship between diabetes and COVID-19. The literature available in the PubMed database was used to carry out a systematic review of the literature. The meta-analyzes from 2021 and 2022 were used for the analysis, with the inclusion of the phrases "DIABETES" and "COVID-19" in the title. A brief description of the state of knowledge: Diabetes does not increase the incidence of COVID-19, but the risk of severe disease is higher in patients with diabetes compared to the non-diabetic population. This is especially true of patients with uncontrolled glycaemia. SARS-CoV-2 disrupts the carbohydrate metabolism, can damage pancreatic beta cells and, in this mechanism, induce diabetes or cause the progression of pre-existing diabetes. There is an increased incidence of COVID-19 complications, including acute respiratory distress syndrome and death in patients with diabetes. Conclusions: Diabetic patients are at a higher risk of the severe course and rapid progression of COVID-19. Important in COVID-19 therapy is glycemic control and monitoring the percentage of glycosylated hemoglobin, CRP and D-dimers. The modification of the current treatment may be necessary. In patients who have undergone COVID-19, attention should be paid to the possibility of induction of diabetes or dysregulation of carbohydrate metabolism in patients suffering from diabetes previously. https://apcz.umk.pl/JEHS/article/view/39559covid-19diabetesSARS-CoV-2 |
spellingShingle | Inga Wasilewska Jakub Rezmer Łukasz Świątek Diabetes mellitus and COVID-19: current state of knowledge Journal of Education, Health and Sport covid-19 diabetes SARS-CoV-2 |
title | Diabetes mellitus and COVID-19: current state of knowledge |
title_full | Diabetes mellitus and COVID-19: current state of knowledge |
title_fullStr | Diabetes mellitus and COVID-19: current state of knowledge |
title_full_unstemmed | Diabetes mellitus and COVID-19: current state of knowledge |
title_short | Diabetes mellitus and COVID-19: current state of knowledge |
title_sort | diabetes mellitus and covid 19 current state of knowledge |
topic | covid-19 diabetes SARS-CoV-2 |
url | https://apcz.umk.pl/JEHS/article/view/39559 |
work_keys_str_mv | AT ingawasilewska diabetesmellitusandcovid19currentstateofknowledge AT jakubrezmer diabetesmellitusandcovid19currentstateofknowledge AT łukaszswiatek diabetesmellitusandcovid19currentstateofknowledge |